COST-EFFECTIVENESS OF CANNABIDIOL (CBD) FOR THE TREATMENT OF SEIZURES IN PATIENTS WITH TREATMENT-RESISTANT LENNOX-GASTAUT SYNDROME OR DRAVET SYNDROME IN THE NETHERLANDS

被引：0
|
作者：
Siddiqui, J. [1 ]
Bowditch, S. [2 ]
机构：
[1] FIECON Ltd, London, England
[2] Jazz Pharmaceut, London, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE400
引用
收藏
页码：S127 / S128
页数：2
相关论文
共 50 条
  • [21] Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
    Devinsky, Orrin
    Patel, Anup D.
    Cross, J. Helen
    Villanueva, Vicente
    Wirrell, Elaine C.
    Privitera, Michael
    Greenwood, Sam M.
    Roberts, Claire
    Checketts, Daniel
    VanLandingham, Kevan E.
    Zuberi, Sameer M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (20): : 1888 - 1897
  • [22] Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain
    Garcia-Penas, Juan J.
    Nagel-Rein, Antonio Gil
    Sanchez-Carpintero, Rocio
    Villanueva-Haba, Vicente
    [J]. REVISTA DE NEUROLOGIA, 2021, 73 : S1 - S8
  • [23] Exposure-Response Analysis of Cannabidiol (CBD) Oral Solution for the Treatment of Lennox-Gastaut Syndrome
    Morrison, Gilmour
    Sardu, Maria Luisa
    Rasmussen, Christian Hove
    Sommerville, Kenneth
    Roberts, Claire
    Blakey, Graham E.
    [J]. NEUROLOGY, 2018, 90
  • [24] Treatment of Lennox-Gastaut syndrome
    Hancock, Eleanor C.
    Cross, J. Helen
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (02):
  • [25] Erratum to: The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK
    Á Benedict
    L Verdian
    G Maclaine
    [J]. PharmacoEconomics, 2011, 29 : 1014 - 1014
  • [26] Treatment of Lennox-Gastaut syndrome
    Hancock, E. C.
    Cross, H. H. J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (03):
  • [27] Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome
    Nabbout, Rima
    Arzimanoglou, Alexis
    Auvin, Stephane
    Berquin, Patrick
    Desurkar, Archana
    Fuller, Douglas
    Nortvedt, Charlotte
    Pulitano, Patrizia
    Rosati, Anna
    Soto, Victor
    Villanueva, Vicente
    Cross, J. Helen
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2023, 110 : 78 - 85
  • [28] Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Wijnen, Ben
    Armstrong, Nigel
    Ramaekers, Bram
    Witlox, Willem
    Westwood, Marie
    Fayter, Debra
    Ryder, Steve
    Buksnys, Titas
    Worthy, Gill
    Misso, Kate
    Grimm, Sabine
    Kleijnen, Jos
    Joore, Manuela
    [J]. PHARMACOECONOMICS, 2020, 38 (10) : 1043 - 1053
  • [29] Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome
    Lattanzi, Simona
    Zaccara, Gaetano
    Russo, Emilio
    La Neve, Angela
    Lodi, Monica Anna Maria
    Striano, Pasquale
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (01) : 99 - 110
  • [30] Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome
    Lattanzi, Simona
    Trinka, Eugen
    Striano, Pasquale
    Rocchi, Chiara
    Salvemini, Sergio
    Silvestrini, Mauro
    Brigo, Francesco
    [J]. CNS DRUGS, 2021, 35 (03) : 265 - 281
12345